Choosing A Male Vitality Supplement: Seven Checks

The front of a male vitality box is legally constrained to say almost nothing, so every box says the same thing. Comparing two products on their front panels is comparing two copies of the same sentence.

Everything that distinguishes one product from another is on the back of the jar and on the seller's website, and it is mostly numeric. The checks below are ordered by how much they tell you per minute spent. The first two will resolve most comparisons on their own.

Each check is written so that the answer is yes or no rather than a judgement. That is deliberate. A scorecard that requires you to already know the literature is not a scorecard, it is a quiz.

Turn the jar over and look at the Supplement Facts panel. Every active should have a milligram figure on its own line. If instead there is a single line reading “Proprietary Blend” with one total and a list of names underneath it, the total is a ceiling shared by everything named.

A proprietary blend is legal and common, and it is not automatically a trick. A small blend total is the problem, because it caps every name at once. Nine names under an 82 mg blend means no single one of them can exceed 82 mg, and realistically each is a fraction of it.

What to do with the answer: if there is no per-ingredient amount, you cannot run check two, and check two is the one that decides whether the product can work. A blend line does not merely withhold information. It makes the most important question unanswerable.

This is the check that decides the purchase, and the table above is all you need to run it for the seven ingredients that dominate the aisle.

The arithmetic is unforgiving because trial doses in this category are large. Ashwagandha's fertility result took 675 mg a day for ninety days. Maca's desire result took between one and a half and three grams a day for twelve weeks. Tribulus's one positive trial was six tablets a day. These are not amounts that fit inside a shared blend line alongside eight other names.

A label can pass check one and still fail check two, and that combination is common: every amount printed, honestly, and every amount an order of magnitude below the research it is borrowing its reputation from.

What to do with the answer: a product that fails check two is not necessarily worthless, but it is not doing what its citations imply. Judge it on the ingredients whose amounts do reach, if any, and disregard the rest of the reference list.

Botanical rows should say which part of the plant was used and how concentrated the extract is. “Ashwagandha root extract” is a different ingredient from “ashwagandha”, and a 10:1 extract is a different ingredient again from a raw powder at the same milligram weight.

This matters because the trials specify it. Ashwagandha's results come from root extract. Nettle's urinary results, in the neighbouring aisle, come from root rather than leaf. Muira puama's traditional preparation uses root and bark. A label naming only the genus has left the most consequential variable open.

Catuaba is the extreme case and the reason this check exists at all. Several distinct plants are sold under that one trade name, and an analysis of fourteen commercial samples found most were not the botanical their labels claimed. On that ingredient, naming the species is the whole of the question.

What to do with the answer: treat an unnamed plant part as an unanswered question rather than a red flag. Plenty of sound products are vague here. It simply means you cannot map the row onto a trial.

This is the check almost nobody runs and it is the most revealing one in the set, because it tests the seller rather than the formula.

Scroll to the bottom of any sales page in this aisle and you will usually find a numbered list of studies. Open three of them at random. A PubMed identifier resolves in one click, so checking whether reference eight is the paper reference eight claims to be takes under a minute each.

What you are looking for is not a disagreement about interpretation. It is whether the identifier points at the named paper at all. A reference list carrying identifiers that resolve to unrelated articles was assembled by somebody who did not open them, and that tells you how the rest of the page was assembled too.

What to do with the answer: a list that checks out earns the rest of the page a degree of trust. A list that does not means every factual claim on that page needs independent confirmation before you rely on it, which in practice means the page is worth nothing to you as a source.

Almost every product in this aisle will show you a lot code and a certificate reference. Those are filing references. They tell you the batch has paperwork, which is a manufacturing requirement rather than an achievement.

What you are actually looking for is different: a named third-party laboratory, a report you can read, and a date. Identity testing confirms the plant is the plant. Purity testing covers heavy metals and microbial limits. For this category specifically, screening for undeclared pharmaceutical ingredients is the test that matters most, given the documented record of adulteration in products sold as herbal.

Seals are not tests. A Good Manufacturing Practice mark describes how a facility documents its process. An FDA-registered-facility line means the regulator knows the factory exists. Neither is a measurement of the contents of your jar, and no dietary supplement is FDA-approved.

What to do with the answer: most products fail this check, so it rarely separates two candidates. It becomes decisive when one of them passes.

The commercial check, and the one that determines what a mistake costs you.

Look for four things: a stated number of days, a starting point for the clock, a telephone number that a human answers, and a written returns procedure that names who pays the postage. A guarantee that says “money back” and nothing else has given you no information.

The clock's starting point is the detail that catches people. A sixty-day window running from the date of purchase behaves very differently from sixty days running from delivery, and a six-month supply bought under a sixty-day window means four of those months fall outside it. That is not a trick, but it is arithmetic worth doing before the larger pack looks like the obvious saving.

What to do with the answer: this check should influence which pack size you buy at least as much as which product you buy.

Every serving carries things that are not the active ingredients, and on a product taken every day for months those add up in a way a single serving disguises.

On chewable and gummy formats, added sugar is the item to read. Three grams a day sounds trivial and is 90 grams a month. The 2021 American Heart Association guidance and the cohort work on added sugar and cardiovascular mortality are the context for whether that matters to you.

Caffeine is the second. It is easy to place: up to 400 mg a day is the figure usually cited for healthy adults, and a 5 oz cup of ground roasted coffee is about 85 mg. A small caffeine row is genuinely small, and it is still worth knowing it is there if you are sensitive or you take the product in the evening.

Third, interactions. Read the cautions for anything you already take. Arginine lowers blood pressure in pooled analysis. Green tea extract and ashwagandha both have published liver case reports at high intakes. None of that makes a product unsafe; it makes the caution line worth reading once rather than never.

What to do with the answer: this check almost never rules a product out. It changes how you take it.

Running a scorecard and then exempting the product beside it would make the previous seven sections decoration, so here is the same seven applied to this jar, with the failures first.

Checks one and two fail together and they fail for the same reason. The panel carries a single active line reading Proprietary Blend at 82 mg, with 9 names beneath it and no amount against any of them. That 82 mg is a ceiling for all 9 at once. Set it beside the trial doses in check two and the comparison finishes itself: 675 mg of ashwagandha, on its own, is a little over eight times the entire blend.

Check four fails on the seller's own sales page rather than on the product. Read on 19 September 2026, that page carried twelve numbered references. Three print an identifier belonging to a different article, and a fourth carries no identifier at all and is marked as being under review. The urologist's guide it names in reference eight and the aphrodisiacs review it names in reference nine are both real papers with correct identifiers of their own, which is how the mismatch was found.

Check five fails the way almost every product in this aisle fails it. Check three is a partial: the panel names extracts and the seller's material names plant parts, but no extract ratio is given anywhere, so the rows still cannot be mapped onto a trial.

Checks six and seven pass, and neither is a formality. Sixty days from the date of purchase with a published returns procedure and a staffed order desk is a better refund position than much of this shelf offers. And printing a real Supplement Facts panel, with the caffeine broken out and the added sugar stated, puts VigorHorse ahead of the products in this category that publish no panel at all.

The answer is not automatically to walk away, and pretending otherwise on a page that sells the jar would be its own kind of dishonesty.

What four failures mean precisely is this: the research on the nine names cannot be used as a prediction about this jar. Whatever this product does for the people who reorder it, it is not doing it by delivering the doses those trials used, because the arithmetic rules that out. So the citations are context for the ingredients rather than evidence about the serving.

What remains is what the panel prints and what the desk offers. A daily gummy at 5 mg of caffeine and 3 g of added sugar, 30 to a jar, with 60 days from purchase to return it. A buyer who wants a small daily habit and has read check two knows exactly what they are buying and what they are not. That is a defensible purchase. A buyer expecting the ashwagandha trial result is buying something this label cannot supply, and check two is where that should have become clear.

The one substitution worth naming: if a specific ingredient on this page interested you, single-ingredient products exist at the trial doses, and check two is easy to run on those.